(781)843-5491 [email protected]
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • Contact
MVG Consulting Services
  • Services and Capabilities
    • Clinical Development
      • Clinical Development Programs
        • Pre-Study
        • Ongoing Studies
        • Marketing Applications
        • Clinical Operations
        • Clinical Project Management
      • Project Rescue
      • Clinical Study Support
      • Data Management
      • Medical Writing
      • Trial Master File (TMF) and eTMF Management
    • Inspection Readiness
    • Quality Assurance
      • Auditing
      • Gap Analysis and Remediation
      • Clinical Quality Systems
        • SOP Development
        • Internal Training
      • Customized QA Consulting
      • Computer System Validation
    • REMS Project Management
    • CRO Alternative
      • Hybrid Model
      • Managed CRO
      • CRO Remediation
  • About MVG
    • Why MVG
    • Our Team
  • MVG Insights
    • Case Studies
    • Blog/Newsletters
Select Page

Next Generation Of COVID-19 Virus Tests Could Get Faster And Cheaper With CRISPR : Shots – Health News : NPR

by MVG Consulting | Apr 22, 2020 | Clinical Trials

As the demand for COVID-19 testing continues to outpace supply, CRISPR emerges with innovative and promising potential to fill that gap.   Researchers are racing to develop quick, home-based tests for the virus that could deliver test results in minutes. None do...

FDA Issues New Guidances in Response to COVID-19.

by MVG Consulting | Apr 16, 2020 | Featured, Industry News

MVG Insights In lieu of the COVID-19 outbreak, the FDA has issued 3 clinical guidances outlining new protocols related to the following: REMS requirements, alcohol-based sanitizer production, and the conduct of clinical trials of medical products. Each guidance...

Risk Evaluation and Mitigation Strategies (REMS) Programs & MVG

by MVG Consulting | Apr 6, 2020 | Company News, Featured

A look into Risk Evaluation and Mitigation Strategies (REMS) programs and how MVG can help. MVG Insights: REMS Monday, April 6, 2020 Risk Evaluation and Mitigation Strategies (REMS) programs were instituted as part of the FDA Amendments Act (FDAAA) in 2007 to provide...

Recent Posts

  • Newly Approved REMS Programs 2025 and Evolving Trends
  • Draft FDA Guidance – Protocol Deviations
  • Guideline for Good Clinical Practice – Key Changes in ICH E6 R3
  • Celebrating 25 Years of MVG Consulting!
  • The Evolution of FDA Recommendations on Real World Evidence and Real World Data

Categories

  • Clinical Trials
  • Company News
  • Featured
  • Industry News
  • Instagram

Archives

  • April 2025
  • March 2025
  • February 2025
  • August 2023
  • August 2022
  • February 2022
  • January 2022
  • September 2021
  • August 2021
  • July 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018

MVG Consulting Services Inc.  •  400 Washington Street | Suite 403, Braintree MA 02184  •  Phone: (781)843-5491  •  Fax: 781.843.3087  •  EMail: [email protected]

Website by Nisse Designs   |   ©2025 MVG Consulting Services Inc.